HMGB2 in cartilage homeostasis, aging and osteoarthritis

HMGB2 在软骨稳态、衰老和骨关节炎中的作用

基本信息

  • 批准号:
    8500208
  • 负责人:
  • 金额:
    $ 38.58万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-07-01 至 2015-06-30
  • 项目状态:
    已结题

项目摘要

6. PROJECT SUMMARY/ABSTRACT Osteoarthritis (OA) is the most prevalent joint disease and a major cause of disability. Aging is the major risk factor for OA which begins with disruption of the cartilage superficial zone (SZ). Molecular mechanisms that determine the unique phenotype of cells in the SZ are unknown and information on causes of the initial cartilage surface defects is limited. Our preliminary studies show that the chromatin protein HMGB2 is exclusively expressed in the SZ of articular cartilage. We examined Hmgb2-/- mice and found more severe OA as compared to wild-type (WT) mice. In human and WT mouse joints there is an aging-related reduction and loss of HMGB2 expression followed by degenerative changes in the cartilage surface. These findings support our hypothesis that HMGB2 is involved in cartilage homeostasis and aging-related loss of HMGB2 expression is a mechanism involved in disruption of the SZ and early OA. The goals of the proposed study are to investigate how aging-related reduction of HMGB2 affects cartilage integrity and address molecular and cellular mechanisms of HMGB2. Aim 1. HMGB2 deficiency in murine and human joints. We will analyze onset, evolution and patterns of cartilage degeneration in Hmgb2-/- mice and examine mechanisms of OA pathogenesis in Hmgb2-/- mice involved in spontaneous and surgically induced OA. These findings will be confirmed with human articular cartilage. Aim 2. HMGB2 in articular chondrocytes. We will characterize phenotype and differentiation status of HMGB2-expressing cells. Studies will be performed on regulation of HMGB2 expression in cultured chondrocytes and we will determine the role of HMGB2 in regulating survival and biosynthetic responses in SZ chondrocytes. Aim 3. Mechanisms of HMGB2 regulation of cell function: interactions with Lef-1 and ss-catenin. We will map essential motifs involved in the physical interaction of HMGB2 and Lef-1. We will address function of ss- catenin interaction with HMGB2 and in expression of Lef-1 dependent genes, SZP and survival genes. Superficial zone-specific deletion of ss-catenin will be obtained by conditional knock out of ss-catenin by intraarticular injection of adenovirus expressing Cre recombinase. The proposed studies have the potential to generate new insight into molecular mechanisms that control the unique differentiation status of SZ chondrocytes. This information will not only be relevant to OA but also to cartilage tissue engineering. The proposed studies will provide insights into mechanisms of early degenerative changes in the articular cartilage and may permit development of preventive and therapeutic strategies for OA.
6. 项目总结/文摘

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Martin K Lotz其他文献

New approach to testing treatments for osteoarthritis: FastOA
骨关节炎治疗测试新方法:快速骨关节炎评估法
  • DOI:
    10.1136/ard-2023-224675
  • 发表时间:
    2024-03-01
  • 期刊:
  • 影响因子:
    20.600
  • 作者:
    David Felson;Martin K Lotz;Yuxuan Jin;Morgan Jones;Jason S Kim;Kurt Spindler
  • 通讯作者:
    Kurt Spindler

Martin K Lotz的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Martin K Lotz', 18)}}的其他基金

Mapping the joint-nerve interactome of the knee
绘制膝关节的关节神经相互作用组图
  • 批准号:
    10861323
  • 财政年份:
    2023
  • 资助金额:
    $ 38.58万
  • 项目类别:
Mapping the joint-nerve interactome of the knee
绘制膝关节的关节神经相互作用组图
  • 批准号:
    10607479
  • 财政年份:
    2022
  • 资助金额:
    $ 38.58万
  • 项目类别:
High resolution 3D mapping of cellular heterogeneity within multiple types of mineralized tissues
多种矿化组织内细胞异质性的高分辨率 3D 绘图
  • 批准号:
    10705190
  • 财政年份:
    2020
  • 资助金额:
    $ 38.58万
  • 项目类别:
High resolution 3D mapping of cellular heterogeneity within multiple types of mineralized tissues
多种矿化组织内细胞异质性的高分辨率 3D 绘图
  • 批准号:
    10267740
  • 财政年份:
    2020
  • 资助金额:
    $ 38.58万
  • 项目类别:
High resolution 3D mapping of cellular heterogeneity within multiple types of mineralized tissues
多种矿化组织内细胞异质性的高分辨率 3D 绘图
  • 批准号:
    10700252
  • 财政年份:
    2020
  • 资助金额:
    $ 38.58万
  • 项目类别:
High resolution 3D mapping of cellular heterogeneity within multiple types of mineralized tissues
多种矿化组织内细胞异质性的高分辨率 3D 绘图
  • 批准号:
    10816791
  • 财政年份:
    2020
  • 资助金额:
    $ 38.58万
  • 项目类别:
FOXO transcription factors as critical regulators of intervertebral disc aging
FOXO转录因子作为椎间盘老化的关键调节因子
  • 批准号:
    10617735
  • 财政年份:
    2019
  • 资助金额:
    $ 38.58万
  • 项目类别:
FOXO transcription factors as critical regulators of intervertebral disc aging
FOXO转录因子作为椎间盘老化的关键调节因子
  • 批准号:
    10399475
  • 财政年份:
    2019
  • 资助金额:
    $ 38.58万
  • 项目类别:
FoxO transcription factors in joint aging and osteoarthritis pathogenesis
FoxO转录因子在关节衰老和骨关节炎发病机制中的作用
  • 批准号:
    10399471
  • 财政年份:
    2018
  • 资助金额:
    $ 38.58万
  • 项目类别:
KLF4 in joint degradation and regeneration
KLF4 在关节降解和再生中的作用
  • 批准号:
    9927548
  • 财政年份:
    2018
  • 资助金额:
    $ 38.58万
  • 项目类别:

相似海外基金

cGAS-STING Pathway Targeting Replicative Adenoviruses with CD46 Tropism and AFP Promoter Conditional Replication Restriction for the Treatment of Hepatocellular Carcinoma
cGAS-STING 通路靶向具有 CD46 趋向性和 AFP 启动子的复制腺病毒条件性复制限制用于治疗肝细胞癌
  • 批准号:
    10436626
  • 财政年份:
    2021
  • 资助金额:
    $ 38.58万
  • 项目类别:
Glioma therapy with oncolytic adenoviruses and immunometabolic adjuvants
溶瘤腺病毒和免疫代谢佐剂治疗胶质瘤
  • 批准号:
    10557162
  • 财政年份:
    2021
  • 资助金额:
    $ 38.58万
  • 项目类别:
Molecular therapy of replication-competent adenoviruses targeting characteristic gene mutations found in mesothelioma
针对间皮瘤中发现的特征基因突变的具有复制能力的腺病毒的分子疗法
  • 批准号:
    21K08199
  • 财政年份:
    2021
  • 资助金额:
    $ 38.58万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Glioma therapy with oncolytic adenoviruses and immunometabolic adjuvants
溶瘤腺病毒和免疫代谢佐剂治疗胶质瘤
  • 批准号:
    10330464
  • 财政年份:
    2021
  • 资助金额:
    $ 38.58万
  • 项目类别:
Structural characterization of nucleoprotein cores of human adenoviruses
人腺病毒核蛋白核心的结构表征
  • 批准号:
    9807741
  • 财政年份:
    2019
  • 资助金额:
    $ 38.58万
  • 项目类别:
Molecular biology and pathogenesis of fowl adenoviruses
禽腺病毒的分子生物学和发病机制
  • 批准号:
    41625-2013
  • 财政年份:
    2018
  • 资助金额:
    $ 38.58万
  • 项目类别:
    Discovery Grants Program - Individual
The therapeutic strategies with augmented replications of oncolytic adenoviruses for malignant mesothelioma
溶瘤腺病毒增强复制治疗恶性间皮瘤的治疗策略
  • 批准号:
    18K15937
  • 财政年份:
    2018
  • 资助金额:
    $ 38.58万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Molecular biology and pathogenesis of fowl adenoviruses
禽腺病毒的分子生物学和发病机制
  • 批准号:
    41625-2013
  • 财政年份:
    2017
  • 资助金额:
    $ 38.58万
  • 项目类别:
    Discovery Grants Program - Individual
Exploring the effects of nutrient deprivation on T cells and oncolytic adenoviruses, in order to create immune activators for tumour therapy
探索营养剥夺对 T 细胞和溶瘤腺病毒的影响,以创造用于肿瘤治疗的免疫激活剂
  • 批准号:
    1813152
  • 财政年份:
    2016
  • 资助金额:
    $ 38.58万
  • 项目类别:
    Studentship
Research on detection of novel adenoviruses by genetic methods
新型腺病毒的基因检测研究
  • 批准号:
    16K09118
  • 财政年份:
    2016
  • 资助金额:
    $ 38.58万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了